Fluctuations in the gene expression of peripheral blood mononuclear cells between the active and inactive phases of systemic lupus erythematosus

Clinical and Experimental Rheumatology

Volumn 28, Issue 3, 2010, Pages 311-317

  Kawasaki, Mikiko ^a   Fujishiro, Maki ^a   Yamaguchi, Ayako ^a,b   Nozawa, Kazuhisa ^a,c   Kaneko, Hiroshi ^c   Takasaki, Yoshinari ^b   Takamori, Kenji ^a   Ogawa, Hideoki ^a   Sekigawa, Iwao ^a,c  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

DNA microarrays; Genetic translation; Interferons; Ribosomal proteins; Systemic lupus erythematosus

Indexed keywords

BONE MARROW STROMAL CELL ANTIGEN 2; CELL ANTIGEN; CYCLOPHILIN B; CYCLOPHOSPHAMIDE; CYTOKINE; EUKARYOTIC TRANSLATION ELONGATION FACTOR 1 BETA 2; EUKARYOTIC TRANSLATION INITIATION FACTOR 3 SUBUNIT 6; EUKARYOTIC TRANSLATION INITIATION FACTOR 3 SUBUNIT 6 INTERACTING PROTEIN; HYALURONOGLUCOSAMINIDASE; HYALURONOGLUCOSAMINIDASE 2; IMMUNOSUPPRESSIVE AGENT; INTERFERON ALPHA INDUCIBLE PROTEIN 6; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 1; INTERFERON REGULATORY FACTOR 7; MEMBRANE PROTEIN; NUCLEIC ACID BINDING PROTEIN; PREDNISOLONE; PROTEIN ARPC5L; PROTEIN ISG15; PROTEIN ISG20; RIBOSOME PROTEIN; RIBOSOME PROTEIN L23; RIBOSOME PROTEIN S11; RIBOSOME PROTEIN S27A; RIBOSOME PROTEIN S5; STEROID; THYROID HORMONE RECEPTOR ALPHA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 257;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; ACUTE DISEASE; CHRONIC DISEASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MIDDLE AGED; MONONUCLEAR CELL; PHYSIOLOGY;

ACUTE DISEASE; ADOLESCENT; ADULT; CHRONIC DISEASE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 77957007721     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. SEKIGAWA I, KAWASAKI M, OGASAWARA H et al.: DNA methylation: its contribution to systemic lupus erythematosus. Clin Exp Med 2006; 6: 99-106.
2. SEKIGAWA I, NAITO T, HIRA K et al.: Possible mechanisms of gender bias in SLE: new hypothesis involving a comparison of SLE with atopy. Lupus 2004; 13: 217-22.
3. SEKIGAWA I, OGASAWARA H, KANEKO H, HISHIKAWA T, HASHIMOTO H: Retroviruses and autoimmunity. Intern Med 2001 ; 40: 80-6.
4. KAWASAKI M, SEKIGAWA I, NOZAWA K et al.: Changes in the gene expression of peripheral blood mononuclear cells during the menstrual cycle of females is associated with a gender bias in the incidence of systemic lupus erythematosus. Clin Exp Rheumatol 2009; 27: 260-6.
5. KAWASAKI M, KANEDA K, KANEKO H, SEKIGAWA I, TAKASAKI Y, OGAWA H: Two cases of dermatomyositis associated with interstitial pneumonia: a comprehensive study of gene expression. Clin Exp Rheumatol 2008; 26: 379-80.
6. LEE HM, MIMA T, SUGINO H et al.: Interactions among type I and type II interferon, tumor necrosis factor, and beta-estradiol in the regulation of immune response-related gene expressions in systemic lupus erythematosus. Arthritis Res Ther 2009; 11 : R1.
7. NAKOU M, KNOWLTON N, FRANK MB et al.: Gene expression in systemic lupus erythematosus: bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signatures Arthritis Rheum 2008; 58: 3541-9.
8. NIKPOUR M, DEMPSEY AA, UROWITZ MB, GLADMAN DD, BARNES DA: Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus. Ann Rheum Dis 2008; 67: 1069-75
9. DAI Y, HUANG YS, TANG M et al: Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 2007; 16: 939-46.
10. GLADKEVICHA, NELEMANS SA, KAUFFMAN HF, KORF J: Microarray profiling of lymphocytes in internal diseases with an altered immune response: potential and methodology. Mediators Inflamm 2005; 2005: 317-30.
11. QING X, PUTTERMAN C: Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus. Autoimmun Rev 2004; 3: 505-9.
12. TAN EN, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
13. BOMBARDIER C, GLADMAN DD, UROWITZ MB, CARON D, CHANG CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 1992; 35: 630-40.
14. TAKAOKA A, YANAI H, KONDO S et al.: Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005; 434: 243-9.
15. RICHEZ C, YASUDA K, WATKINS AA et al.: TLR4 ligands induce IFN-alpha production by mouse conventional dendritic cells and human monocytes after IFN-beta priming. J Immunol 2009; 182: 820-8.
16. YASUDA K, RICHEZ C, MACIASZEK JW et al.: Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. J Immunol 2007; 178: 6876-85.
17. FENG X, WU H, GROSSMAN JM et al.: Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2951-62.
18. HUA J, KIROU K, LEE C, CROW MK: Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum 2006; 54: 1906-16.
19. SCHILD-HAY LJ, LEIL TA, DIVI RL, OLIVERO OA, WESTON A, POIRIER MC: Tamoxifen induces expression of immune response-related genes in cultured normal human mammary epithelial cells. Cancer Res 2009; 69: 1150-5.
20. ABDEL-NASSER AM, GHALEB RM, MAHMOUD JA, KHAIRY W, MAHMOUD RM: Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus. Clin Rheumatol 2008; 27: 1377-85.
21. HANLY JG, UROWITZ MB, SIANNIS F et al.: Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum 2008; 58: 843-53.
22. TOUBI E, SHOENFELD Y: Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun Rev 2007; 6: 119-25.
23. CHAMBERS DM, ROULEAU GA, ABBOTT CM: Comparative genomic analysis of genes encoding translation elongation factor 1B(alpha) in human and mouse shows EEF1B1 to be a recent retrotransposition event. Genomics 2001; 77: 145-8.
24. MORRIS-DESBOIS C, RETY S, FERRO M, GARIN J, JALINOT P: The human protein HSPC021 interacts with Int-6 and is associated with eukaryotic translation initiation factor 3. J Biol Chem 2001; 276: 45988-95.
25. PILTTI J, HÄYRINEN J, KARJALAINEN HM, LAMMI MJ: Proteomics of chondrocytes with special reference to phosphorylation changes of proteins in stretched human chondrosarcoma cells. Biorheology 2008; 45: 323-35.
26. SORDET C, GOETZ J, SIBILIA J: Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. Joint Bone Spine 2006; 73: 646-54.